Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1900 1
1901 3
1908 1
1909 1
1912 1
1915 1
1919 1
1920 1
1962 1
1970 1
1973 1
1974 2
1987 1
1991 1
1992 2
1993 3
1994 2
1996 2
1997 2
1998 3
1999 3
2000 2
2001 5
2002 2
2004 3
2005 4
2006 6
2007 3
2008 5
2009 4
2010 3
2011 2
2012 6
2013 9
2014 15
2015 9
2016 5
2017 3
2018 5
2020 6
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

125 results
Results by year
Filters applied: . Clear all
Page 1
Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial.
Fitzgerald KN, Hodges R, Hanes D, Stack E, Cheishvili D, Szyf M, Henkel J, Twedt MW, Giannopoulou D, Herdell J, Logan S, Bradley R. Fitzgerald KN, et al. Among authors: stack e. Aging (Albany NY). 2021 Apr 12;13(7):9419-9432. doi: 10.18632/aging.202913. Epub 2021 Apr 12. Aging (Albany NY). 2021. PMID: 33844651 Free PMC article. Clinical Trial.
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation.
Taube JM, Akturk G, Angelo M, Engle EL, Gnjatic S, Greenbaum S, Greenwald NF, Hedvat CV, Hollmann TJ, Juco J, Parra ER, Rebelatto MC, Rimm DL, Rodriguez-Canales J, Schalper KA, Stack EC, Ferreira CS, Korski K, Lako A, Rodig SJ, Schenck E, Steele KE, Surace MJ, Tetzlaff MT, von Loga K, Wistuba II, Bifulco CB; Society for Immunotherapy of Cancer (SITC) Pathology Task Force.. Taube JM, et al. Among authors: stack ec. J Immunother Cancer. 2020 May;8(1):e000155. doi: 10.1136/jitc-2019-000155. J Immunother Cancer. 2020. PMID: 32414858 Free PMC article.
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent.
Xu K, Wu ZJ, Groner AC, He HH, Cai C, Lis RT, Wu X, Stack EC, Loda M, Liu T, Xu H, Cato L, Thornton JE, Gregory RI, Morrissey C, Vessella RL, Montironi R, Magi-Galluzzi C, Kantoff PW, Balk SP, Liu XS, Brown M. Xu K, et al. Among authors: stack ec. Science. 2012 Dec 14;338(6113):1465-9. doi: 10.1126/science.1227604. Science. 2012. PMID: 23239736 Free PMC article.
Regulation of cyclo-oxygenase-2.
Stack E, DuBois RN. Stack E, et al. Best Pract Res Clin Gastroenterol. 2001 Oct;15(5):787-800. doi: 10.1053/bega.2001.0235. Best Pract Res Clin Gastroenterol. 2001. PMID: 11566041 Review.
Harm Reduction and Adaptations Among PWUD in Rural Oregon During COVID-19.
Seaman A, Leichtling G, Stack E, Gray M, Pope J, Larsen JE, Leahy JM, Gelberg L, Korthuis PT. Seaman A, et al. Among authors: stack e. AIDS Behav. 2021 May;25(5):1331-1339. doi: 10.1007/s10461-020-03141-4. Epub 2021 Jan 20. AIDS Behav. 2021. PMID: 33471243 Free PMC article.
Multiplexed tissue biomarker imaging.
Stack EC, Foukas PG, Lee PP. Stack EC, et al. J Immunother Cancer. 2016 Feb 16;4:9. doi: 10.1186/s40425-016-0115-3. eCollection 2016. J Immunother Cancer. 2016. PMID: 26885371 Free PMC article. No abstract available.
Novel technologies and emerging biomarkers for personalized cancer immunotherapy.
Yuan J, Hegde PS, Clynes R, Foukas PG, Harari A, Kleen TO, Kvistborg P, Maccalli C, Maecker HT, Page DB, Robins H, Song W, Stack EC, Wang E, Whiteside TL, Zhao Y, Zwierzina H, Butterfield LH, Fox BA. Yuan J, et al. Among authors: stack ec. J Immunother Cancer. 2016 Jan 19;4:3. doi: 10.1186/s40425-016-0107-3. eCollection 2016. J Immunother Cancer. 2016. PMID: 26788324 Free PMC article. Review.
Physiotherapy: the ultimate placebo.
Stack E. Stack E. Physiother Res Int. 2006 Sep;11(3):127-8. doi: 10.1002/pri.342. Physiother Res Int. 2006. PMID: 17019941 No abstract available.
125 results